• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • Clinical Trial Listings
    • What are Clinical Trials?
    • Become a Clinical Trial Volunteer
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Market Research
    • Benchmark Reports
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
  • White Papers
  • Clinical Trial Listings
  • Advertise
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » The CenterWatch Weekly, December 05, 2016

The CenterWatch Weekly, December 05, 2016

December 5, 2016
CenterWatch Staff

IDEA Pharma, Mass Innovation Labs partner to reshape the development paradigm

Can the spirit of entrepreneurialism and impactful agile practices disrupt and improve upon the traditional models of scientific development? That question is at the heart of a new partnership between IDEA Pharma and Mass Innovation Labs. The two organiza­tions are now collaborating in an effort to stimulate innovation and address problems that established internal pharmaceutical models struggle to solve. The joint ven­ture, called SkunkWeeks—a variation of the phrase skunkworks, which is used to describe when teams in research and devel­opment or tech flee their traditional work confines to inspire outside-the-box thinking and innovation—launched in September.

Evolving priorities in behavioral and social science research

The Office of Behavioral and Social Science Research (OBSSR), part of the NIH intends to shift the paradigm of research in behavioral and social sciences (BSS) and outlined its intentions in a new five-year strategic plan for fiscal years 2017 through 2021. Clinical trials professionals may find these key points of interest when designing and implementing future trials in BSS. The OBSSR Strategic Plan 2017-2021 lists three scientific priorities, William Riley, Ph.D., director of the OBSSR and associate director for Behavioral and Social Sciences Research at the NIH, explained. The first is to improve the synergy in these fields of research.

 

To read the full articles for this issue of The CenterWatch Weekly, please click here for subscription information.

    Upcoming Events

    • 05Dec

      Thriving in Clinical Research – Overcoming Common Challenges as a Site: Part 3 – Site Resourcing

    • 14Apr

      MAGI 2024: The Clinical Research Conference

    Featured Products

    • Surviving an FDA GCP Inspection

      Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

    • Best Practices for Clinical Trial Site Management

      Best Practices for Clinical Trial Site Management

    Featured Stories

    • Jonathan Seltzer

      Thought Leadership: Remote Patient Monitoring Gives New View of Safety in Cardiac Clinical Trials

    • Quality_Compass-360x240.png

      Ask the Experts: Applying Quality by Design to Protocols

    • Obesity Treatment Patient

      Clinical Trials Need Greater Representation of Obese Patients, Experts Say

    • Modernize-360x240.png

      FDA IT Modernization Plan Prioritizes Data-Sharing, AI, Collaboration and More

    Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

    The information you need to adapt your monitoring plan to changing times.

    Learn More Here
    • About Us
    • Contact Us
    • Privacy Policy
    • Do Not Sell or Share My Data

    Footer Logo

    300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

    Phone 703.538.7600 – Toll free 888.838.5578

    Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing